суббота, 5 апреля 2008 г.

Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamus-pituitary-adrenal axis and immune system activity at school age

No.April 2008, pp.(doi:10.This Article Services Citing Articles Google Scholar PubMed Related Collections ARTICLE NEONATAL DEXAMETHASONE TREATMENT FOR CHRONIC LUNG DISEASE OF PREMATURITY ALTERS THE HYPOTHALAMUS-PITUITARY-ADRENAL AXIS AND IMMUNE SYSTEM ACTIVITY AT SCHOOL AGE ROSA KAREMAKER, MD, PHDA,B, ANNEMIEKE KAVELAARS, PHDB, MAIKE TER WOLBEEK, PHDB, MARIJKE TERSTEEG-KAMPERMANB, WIM BAERTS, MD, PHDC, SYLVIA VEEN, MD, PHDD, JANNIE F.MD, PHDE, GERARD H.MD, PHDF, FRANK VAN BEL, MD, PHDA AND COBI J.A Department of Neonatology b Laboratory of Psychoneuroimmunology f Department of Obstetrics and Gynaecology, University Medical Center Utrecht, Utrecht, Netherlands c Department of Neonatology, Isala Clinics Zwolle, Zwolle, Netherlands d Department of Neonatology, University Medical Center Leiden, Leiden, Netherlands e Department of Neonatology, VU University Medical Center, Amsterdam, Netherlands OBJECTIVE.Long-term effects of neonatal treatment with dexamethasone or hydrocortisone for chronic lung disease of prematurity on the hypothalamus-pituitary-adrenal axis and the immune response in children at school age.PATIENTS AND METHODS.
Read more Are coenzyme q10 and fish oils safe in type 2 diabetics?
Get more A comparison of atenolol and nebivolol in isolated systolic hypertension.